Innovation Journal, Delivery Science Pensive Beauty Innovation Journal, Delivery Science Pensive Beauty

The Emulsion They Said Couldn’t Exist: Inside the Tri-Domain Architecture of NanoBase™

In 1949, William Griffin published the Hydrophilic-Lipophilic Balance. Seventy-five years later, HLB still runs most of the cosmetic category — and it still does not account for surface charge, colloidal energy barriers, particle size, Ostwald ripening, or multi-carrier specificity. NanoBase™ was built to close those five gaps, simultaneously, on a single lecithin chassis.

Read More
Nano-Delivery, Regulatory, Formulation Science Pensive Beauty Nano-Delivery, Regulatory, Formulation Science Pensive Beauty

Nanocosmetic Regulation in 2026: EU, FDA, and ISO Standards for Sub-Micron Delivery Systems

Regulatory framework for sub-micron cosmetic formulas in 2026. EU Cosmetics Regulation 1223/2009 nano notification, FDA voluntary nano guidance, and ISO 29701 and 80004 standards relevant to brands building on NanoBase™, the tri-domain nano-colloidal Architecture engineered by Pensive Beauty® Nanoscience Labs.

Read More

Nanoemulsion vs Nanoliposome vs Nanomicelle: Comparing Carrier Architectures for Cosmeceutical Delivery

Head-to-head technical comparison of three dominant nano-carrier architectures for cosmeceutical delivery: nanoemulsions (40 to 200 nm droplets), nanoliposomes (phospholipid bilayer vesicles), and nanomicelles (5 to 100 nm surfactant aggregates). Loading capacity, stability, stratum corneum penetration pathways, and why NanoBase™ tri-domain architecture from Pensive Beauty Labs outperforms single-class carriers.

Read More
Nano Delivery Science, Technical Review Pensive Beauty Nano Delivery Science, Technical Review Pensive Beauty

Why Most Skincare Actives Never Reach the Dermis

Conventional emulsions produce 1-100 µm carriers against a stratum corneum barrier with 10-50 nm intercellular spacing. NanoBase™, a tri-domain nano-colloidal Architecture engineered to a ~185 nm design target and DLS-characterised every batch, is designed to address all three HLB barriers at the formulation level.

Read More